These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15591104)

  • 41. Adenosine A1 agonist at reperfusion trial (AART): results of a three-center, blinded, randomized, controlled experimental infarct study.
    Baxter GF; Hale SL; Miki T; Kloner RA; Cohen MV; Downey JM; Yellon DM
    Cardiovasc Drugs Ther; 2000 Dec; 14(6):607-14. PubMed ID: 11300361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
    Faisy C; Risse PA; Naline E; Guerot E; Fagon JY; Devillier P; Advenier C
    Life Sci; 2006 Oct; 79(20):1929-35. PubMed ID: 16820175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amp 579 reduces contracture and limits infarction in rabbit heart by activating adenosine A2 receptors.
    Xu Z; Downey JM; Cohen MV
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):474-81. PubMed ID: 11486252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
    Vander Heide RS; Reimer KA
    Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of adenosine A2A agonism and methylprednisolone in attenuating neuronal damage and improving functional outcome after experimental traumatic spinal cord injury in rabbits.
    Okonkwo DO; Reece TB; Laurent JJ; Hawkins AS; Ellman PI; Linden J; Kron IL; Tribble CG; Stone JR; Kern JA
    J Neurosurg Spine; 2006 Jan; 4(1):64-70. PubMed ID: 16506468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats.
    Makhay MM; Houslay MD; O'Donnell JM
    Psychopharmacology (Berl); 2001 Nov; 158(3):297-304. PubMed ID: 11713620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram.
    Sullivan GW; Linden J; Buster BL; Scheld WM
    J Infect Dis; 1999 Nov; 180(5):1550-60. PubMed ID: 10515815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol.
    Au BT; Teixeira MM; Collins PD; Williams TJ
    Br J Pharmacol; 1998 Mar; 123(6):1260-6. PubMed ID: 9559913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs.
    Padilla F; Garcia-Dorado D; Agulló L; Barrabés JA; Inserte J; Escalona N; Meyer M; Mirabet M; Pina P; Soler-Soler J
    Cardiovasc Res; 2001 Aug; 51(3):592-600. PubMed ID: 11476750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Type IV phosphodiesterase inhibitor suppresses insulin-dependent myocardial glucose uptake.
    Imahashi K; Yoshioka J; Yamakita T; Yamano S; Kusuoka H; Nishimura T
    Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):290-1. PubMed ID: 11251642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sustained cardioprotection afforded by A2A adenosine receptor stimulation after 72 hours of myocardial reperfusion.
    Boucher M; Wann BP; Kaloustian S; Massé R; Schampaert E; Cardinal R; Rousseau G
    J Cardiovasc Pharmacol; 2005 May; 45(5):439-46. PubMed ID: 15821439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
    Silva PM; Alves AC; Serra MF; Pires AL; Silva JP; Barreto EO; Cordeiro RS; Jose PJ; Teixeira MM; Lagente V; Martins MA
    Br J Pharmacol; 2001 Sep; 134(2):283-94. PubMed ID: 11564646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenosine 2B Receptor Activation Reduces Myocardial Reperfusion Injury by Promoting Anti-Inflammatory Macrophages Differentiation via PI3K/Akt Pathway.
    Tian Y; Piras BA; Kron IL; French BA; Yang Z
    Oxid Med Cell Longev; 2015; 2015():585297. PubMed ID: 26161239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bemoradan--a novel inhibitor of the rolipram-insensitive cyclic AMP phosphodiesterase from canine heart tissue.
    Moore JB; Combs DW; Tobia AJ
    Biochem Pharmacol; 1991 Jul; 42(3):679-83. PubMed ID: 1650219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
    Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ
    Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size.
    Valls-Lacalle L; Barba I; Miró-Casas E; Ruiz-Meana M; Rodríguez-Sinovas A; García-Dorado D
    Sci Rep; 2018 Feb; 8(1):2442. PubMed ID: 29402957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenosine A2A activation attenuates nontransplantation lung reperfusion injury.
    Ellman PI; Reece TB; Law MG; Gazoni LM; Singh R; Laubach VE; Linden J; Tribble CG; Kron IL
    J Surg Res; 2008 Sep; 149(1):3-8. PubMed ID: 17937935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel Synthesized Radical-Containing Nanoparticles Limit Infarct Size Following Ischemia and Reperfusion in Canine Hearts.
    Asanuma H; Sanada S; Yoshitomi T; Sasaki H; Takahama H; Ihara M; Takahama H; Shinozaki Y; Mori H; Asakura M; Nakano A; Sugimachi M; Asano Y; Minamino T; Takashima S; Nagasaki Y; Kitakaze M
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):501-510. PubMed ID: 29101507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
    Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J
    Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.